Medivation Inc (MDVN.OQ)
22 Jul 2016
U.S. cancer drug company Medivation Inc said on Tuesday it had agreed to provide confidential information to French pharmaceutical company Sanofi SA as part of exploring a sale that would be open to other bidders. | Video
* Sanofi confirms it has entered into a confidentiality agreement with Medivation under which it will be provided due diligence access and confidential information.
* Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC (Bengaluru Newsroom: +1 646 223 8780)
Medtronic Plc said it would buy HeartWare International Inc for about $1.1 billion, bulking up its portfolio of devices for treating heart diseases and pushing deeper into the market for less-invasive surgical products.
* Deal expected to close by October end (Adds details; updates shares)
Medivation Inc said shareholder advisory firm Glass Lewis & Co has recommended the cancer drug maker's stockholders to not support Sanofi SA's efforts to replace the company's board members.
June 24 Medivation Inc said shareholder advisory firm Glass Lewis & Co has recommended the cancer drug maker's stockholders to not support Sanofi SA's efforts to replace the company's board members.
BRIEF-Sanofi announces expiration of Hart-Scott-Rodino waiting period for proposed acquisition of Medivation
* Sanofi announces expiration of hart-scott-rodino waiting period regarding proposed acquisition of medivation Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
NEW YORK, June 13 French drugmaker Sanofi and its takeover target Medivation Inc on Monday said they had filed official materials with the U.S. Securities and Exchange Commission, as their $9.3 billion battle advances to the next phase.
PARIS French drugmaker Sanofi said on Monday that it had filed a request with U.S. authorities to remove the board of Medivation and replace it with eight independent candidates as it seeks to acquire the cancer drug company.
|Johnson & Johnson (JNJ.N)||$125.03||-0.12|
|Sanofi SA (SASY.PA)||€76.60||--|
|Bayer AG (BAYGn.DE)||€92.07||--|
|Bayer AG (BAYE.F)||--||--|
|Orion Corp (001800.KS)||₩937,000.00||+7,000.00|
|TOKAI Corp. (9729.T)||¥3,325||+55.00|
|Bristol-Myers Squibb Co (BMY.N)||$75.68||+0.18|
|Bristol-Myers Squibb Co (BMYMP.PK)||$1,231.90||--|
|Roche Holding Ltd. (ROG.S)||CHF249.80||--|
|Roche Holding Ltd. (RO.S)||CHF252.25||--|
Earnings vs. Estimates
Analyst Research Reports
Provider : Thomson Reuters Stock Report
Provider : ValuEngine, Inc.
Trading Report for (MDVN). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Medivation Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : New Constructs, LLC
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.